Novavax jumped over 6% in premarket trading as it filed for authorization of its COVID-19 vaccine in UK

Tiger Newspress2021-10-27

Novavax jumped over 6% in premarket trading as it filed for authorization of its COVID-19 vaccine in UK.The company today announced the completion of its rolling regulatory submission to the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for authorization of its COVID-19 vaccine candidate. Its application for Conditional Marketing Authorization (CMA) marks the first submission for authorization of a protein-based COVID-19 vaccine in the United Kingdom.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
11